Aspiriant LLC’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $492K | Sell |
631
-25
| -4% | -$19.5K | 0.02% | 199 |
|
|
2025
Q1 | $542K | Buy |
656
+17
| +3% | +$14K | 0.02% | 182 |
|
|
2024
Q4 | $493K | Sell |
639
-139
| -18% | -$107K | 0.02% | 190 |
|
|
2024
Q3 | $689K | Sell |
778
-3,135
| -80% | -$2.78M | 0.03% | 166 |
|
|
2024
Q2 | $3.54M | Buy |
3,913
+3,195
| +445% | +$2.89M | 0.14% | 66 |
|
|
2024
Q1 | $559K | Buy |
718
+9
| +1% | +$7K | 0.02% | 186 |
|
|
2023
Q4 | $414K | Buy |
709
+69
| +11% | +$40.3K | 0.02% | 206 |
|
|
2023
Q3 | $344K | Sell |
640
-59
| -8% | -$31.7K | 0.02% | 209 |
|
|
2023
Q2 | $328K | Buy |
699
+19
| +3% | +$8.91K | 0.02% | 211 |
|
|
2023
Q1 | $234K | Sell |
680
-27
| -4% | -$9.27K | 0.01% | 252 |
|
|
2022
Q4 | $259K | Buy |
+707
| New | +$259K | 0.01% | 232 |
|
|
2021
Q3 | – | Sell |
-1,009
| Closed | -$232K | – | 239 |
|
|
2021
Q2 | $232K | Buy |
+1,009
| New | +$232K | 0.01% | 219 |
|
|
2020
Q4 | – | Sell |
-1,435
| Closed | -$212K | – | 214 |
|
|
2020
Q3 | $212K | Buy |
+1,435
| New | +$212K | 0.02% | 206 |
|
|
2018
Q2 | – | Sell |
-3,137
| Closed | -$243K | – | 255 |
|
|
2018
Q1 | $243K | Buy |
+3,137
| New | +$243K | 0.02% | 213 |
|